120
Participants
Start Date
October 31, 2012
Primary Completion Date
April 30, 2018
Study Completion Date
April 30, 2018
Patients using Wilate as standard of care
Patients with von Willebrand Disease using Wilate for a period of 2 years.
Hospital San Pedro de Alcantara, Cáceres
Virginia Commonwealth University, Richmond
Hospital Fundacion Jiminez Diaz, Madrid
Nicklaus Children's Hospital, Miami
University of Utah, Salt Lake City
Los Angeles Biomedical Research Institute, Torrance
Fundación de la Hemofilia de Salta, Salta
University of Alberta, Edmonton
Vancouver General Hospital, Vancouver
St. John Regional Hospital, Saint John
Eastern Regional Health Authority, St. John's
McMaster University, Hamilton
Children's Hospital of Eastern Ontario, Ottawa
St. Michael's Hospital, Toronto
University Hospital Ostrava, Ostrava-Poruba
Werlhof-Institut, Hanover
Centro Hospitalar Cova da Beira, Covilha
Skåne University Hospital, Malmo
Great Ormond Street Hospital for Children, London
Hospital Pereira Rossell, Montevideo
Sanatorio Americano, Montevideo
Queens University, Kingston
Maisonneuve-Rosemont Hospital, Montreal
Hospital Universitario de Burgos, Burgos
Lead Sponsor
Octapharma
INDUSTRY